MFAM
ADMA icon

Motley Fool Asset Management’s ADMA Biologics ADMA Stock Holding History

Motley Fool Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$907K Sell
100,694
-6,895
-6% -$109K 0.04% 163
2025
Q4 		$1.96M Buy
+107,589
New +$1.81M 0.08% 152
2020
Q4 		– Sell
-718,797
Closed -$1.6M – 159
2020
Q3 		$1.6M Buy
718,797
+47,565
+7% +$130K 0.14% 95
2020
Q2 		$1.97M Buy
671,232
+58,135
+9% +$167K 0.2% 82
2020
Q1 		$1.77M Buy
613,097
+79,715
+15% +$276K 0.23% 75
2019
Q4 		$2.13M Buy
533,382
+86,078
+19% +$375K 0.23% 78
2019
Q3 		$1.99M Buy
447,304
+78,304
+21% +$327K 0.23% 71
2019
Q2 		$1.43M Buy
+369,000
New +$1.63M 0.16% 90

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return